Mar 16, 2021 / 12:00PM GMT
Hartaj Singh - Oppenheimer & Co. Inc., Research Division - Research Analyst
Hi, everyone. Thank you for joining us today. I'm in North Carolina, which is a dreary North Carolina. But wherever you're at, whether New York or elsewhere, welcome to the first presentation of our Oppenheimer Healthcare Conference for me. I have with me Justin Holko from Regeneron, who is a colleague, and I consider also a friend who is joining us to present on behalf of Regeneron.
I was just thinking this morning that it seems so strange that it was a year ago that we had this health care conference. Regeneron was also presenting. But at the same time, we were just starting to deal with the first initial impact of COVID-19. Now we're exiting out of that, knock on wood, and we're here again with Justin. So it's great that some things stay consistent.
So maybe, Justin, what we can do is just start off with you giving us a presentation, a short synopsis of Regeneron and we can go from there.
Justin Holko - Regeneron Pharmaceuticals, Inc. - VP of IR
Great, yes.
Regeneron Pharmaceuticals Inc at Oppenheimer Healthcare Conference (Virtual) Transcript
Mar 16, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers